• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Twitter
  • YouTube
CDE Almería – Centro de Documentación Europea – Universidad de Almería

CDE Almería - Centro de Documentación Europea - Universidad de Almería

Centro de Documentación Europea de la Universidad de Almería

  • HOME
  • WHAT´S ON
    • EU BULLETINS
    • EU NEWS
    • Activities
    • EU Calls and Awards
    • Radio Program «Europe with You»
  • DOCUMENTATION
    • Bibliographic Collection
      • Almería EDC Digital Collection
      • UNIVERSITY OF ALMERIA LIBRARY
    • Documentation by topic
    • EU Media Collection
      • Web Space
      • MEDIATHEQUE REPOSITORY
  • Europe on the net
    • Institutions
    • EU Representation in Spain
    • European information network of Andalusia
    • EU official journal
  • ABOUT US
    • Presentation
    • People
    • Contact
  • English
  • Spanish

COVID-19 vaccination developments in Europe – 1st four-month period 2021

Inicio » EU News » Health » Diseases » COVID-19 vaccination developments in Europe – 1st four-month period 2021

13 de July de 2021

Vaccination against COVID-19 started on 27 December 2020 across the European Union, in a moment of unity.

To date, 4 safe and effective COVID-19 vaccines have been licensed for use in the EU, following positive scientific recommendations from the European Medicines Agency:

BioNTech-Pfizer: On 21 December 2020, the European Commission granted conditional marketing authorisation to the COVID-19 vaccine developed by BioNTech and Pfizer, thus becoming the first COVID-19 vaccine licensed in the EU.

Moderna: On 6 January 2021, the European Commission granted conditional marketing authorisation for the COVID-19 vaccine developed by Moderna, which became the second COVID-19 vaccine authorised in the EU.

AstraZeneca: On 29 January 2021, the European Commission granted conditional marketing authorisation for the COVID-19 vaccine developed by AstraZeneca, making it the third COVID-19 vaccine authorised in the EU.

Johnson & Johnson: On 11 March 2021, the European Commission granted conditional marketing authorisation to the COVID-19 vaccine developed by Janssen Pharmaceutica NV, which became the fourth COVID-19 vaccine authorised in the EU.
Vaccination in the EU

Although the vaccination process is progressing steadily in all EU countries, the pace of vaccination is uneven across Europe, with some countries being more effective in vaccinating their populations.

Population with 1 dose

As of 30 April, 34.4% of the EU population had received at least one dose of any of the EU-licensed vaccines. The countries with the highest percentage of the population vaccinated with at least one of the doses required to achieve immunisation against COVID-19 were: Hungary (44.6% of the population with at least one of the doses), Malta (43.5%), Finland (34.6%), Belgium (31%), and Austria (29.4%).

Countries where the rate of vaccination is slower were: Czech Republic (21.6%), Romania (19.4%), Croatia (18.8%), Latvia (13.4%) and Bulgaria (10.2%).

Population with a full pattern

As of 30 April, 12% of the EU population had received the full course of one of the EU-licensed vaccines and have therefore been immunised against COVID-19.

The countries which, to date, have vaccinated the highest percentage of their citizens are: Malta (23.4% of its population vaccinated), Hungary (20.6%), Denmark (12.5%), Iceland (11.6%) and Liechtenstein (11.6%).

The countries where the number of people immunised through the administration of vaccines were: Norway (7.1%), Croatia (5.1%), Finland (3.5%), Bulgaria (3.3%) and Latvia (2.4%).

More information

COVID-19 Vaccination in Europe

Publicaciones relacionadas:

Commission lists key steps for effective vaccination strategies and vaccines deployment COVID-19 Vaccination in Europe – September Vaccination evolution and hospitalizations in Europe – November EU and US officials discuss efforts to donate and deliver 1.7 billion vaccine doses around the world Coronavirus Present situation and vaccination in Spain

“This is a space for debate. All comments, for or against publication, that are respectful and do not contain expressions that are discriminatory, defamatory or contrary to current legislation will be published”.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Publicaciones relacionadas


Commission lists key steps for effective vaccination strategies and vaccines deployment


COVID-19 Vaccination in Europe – September


Vaccination evolution and hospitalizations in Europe – November


EU and US officials discuss efforts to donate and deliver 1.7 billion vaccine doses around the world


Coronavirus Present situation and vaccination in Spain

Footer

Logotipo en negativo del Centro de Documentación Europea de Almería
  • CDE Almería
  • Edificio Parque Científico-Tecnológico (Pita)
  • Planta: 1ª, Despacho: 2904120.
  • Ctra. Sacramento s/n. Almería (Spain)
  • Teléfono: (+34) 950 015266

HOME
NEWS
DOCUMENTATION
EUROPE ON THE NET
ABOUT US

  • LEGAL NOTICE
  • PRIVACY POLICY
  • COOKIE POLICY
  • ACCESSIBILITY
  • SITEMAP

Copyright © 2023 CDE Almería · Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

<p>El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. ajustes</p>

Politica de privacidad

El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. <a href="/politica-de-cookies" rel="noopener" target="_blank">Más información</a>

Cookies estrictamente necesarias

Las cookies estrictamente necesarias tiene que activarse siempre para que podamos guardar tus preferencias de ajustes de cookies.

Básicamente la web no funcionara bien si no las activas.

Estas cookies son:

  • Comprobación de inicio de sesión.
  • Cookies de seguridad.
  • Aceptación/rechazo previo de cookies.

Si desactivas esta cookie no podremos guardar tus preferencias. Esto significa que cada vez que visites esta web tendrás que activar o desactivar las cookies de nuevo.

Cookies de terceros

Esta web utiliza Google Analytics, Google Tag Manager y Yandex Metrika para recopilar información anónima tal como el número de visitantes del sitio, o las páginas más populares.

Dejar estas cookies activas nos permite mejorar nuestra web.

¡Por favor, activa primero las cookies estrictamente necesarias para que podamos guardar tus preferencias!

Política de cookies

Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. Más información